Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Sitagliptin phosphate monohydrate (Alias: MK-0431 phosphate monohydrate, MK-0431)

Catalog No. T0242L Copy Product Info
Purity: 99.98%
🥰Excellent
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent DPP-IV inhibitor with an IC50 of 19 nM in Caco-2 cell extracts.

Sitagliptin phosphate monohydrate

Copy Product Info
🥰Excellent
Catalog No. T0242L
Alias MK-0431 phosphate monohydrate, MK-0431

Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent DPP-IV inhibitor with an IC50 of 19 nM in Caco-2 cell extracts.

Sitagliptin phosphate monohydrate
Cas No. 654671-77-9
Pack SizePriceUSA StockGlobal StockQuantity
50 mg$37-In Stock
100 mg$50-In Stock
500 mg$108-In Stock
1 g$152-In Stock
1 mL x 10 mM (in DMSO)$39-In Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.98%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent DPP-IV inhibitor with an IC50 of 19 nM in Caco-2 cell extracts.
Targets&IC50
DPP4:19 nM
In vitro
The IC50 of Nelarabine is 25-fold and 113-fold higher than ARAC in T- and B-lineage, respectively. T-ALL cells are eightfold more sensitive to Nelarabine than B-lineage but there is considerable overlap. The efficacy of NEL in T-lineage and B-lineage cell lines is 25-fold and 113-fold less than ARAC, respectively. [1] Nelarabine acts by inhibiting DNA synthesis and inducing apoptosis in susceptible cells. [2]Nelarabine demonstrated significant antineoplastic activity with acceptable toxicity. [3]
SynonymsMK-0431 phosphate monohydrate, MK-0431
Chemical Properties
Molecular Weight523.33
FormulaC16H15F6N5O·H3PO4·H2O
Cas No.654671-77-9
SmilesOP(O)(O)=O.N[C@H](CC1=C(C=C(C(F)=C1)F)F)CC(N2CCN3C(C2)=NN=C3C(F)(F)F)=O.O
Relative Density.no data available
Storage & Solubility Information
Storagestore under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 38 mg/mL (72.61 mM), Sonication is recommended.
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (177.71 mM), Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM1.9108 mL9.5542 mL19.1084 mL95.5420 mL
5 mM0.3822 mL1.9108 mL3.8217 mL19.1084 mL
10 mM0.1911 mL0.9554 mL1.9108 mL9.5542 mL
20 mM0.0955 mL0.4777 mL0.9554 mL4.7771 mL
50 mM0.0382 mL0.1911 mL0.3822 mL1.9108 mL
DMSO
1mg5mg10mg50mg
100 mM0.0191 mL0.0955 mL0.1911 mL0.9554 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Sitagliptin phosphate monohydrate | purchase Sitagliptin phosphate monohydrate | Sitagliptin phosphate monohydrate cost | order Sitagliptin phosphate monohydrate | Sitagliptin phosphate monohydrate chemical structure | Sitagliptin phosphate monohydrate in vitro | Sitagliptin phosphate monohydrate formula | Sitagliptin phosphate monohydrate molecular weight